Overview
Portfolio
More
Bocggp
Shenzhen, China
Focus on innovative biotech, medical device, and med‑tech companies with growth and buyout strategies, leveraging industry experience and international insights.
Portfolio
9+
Employees
5+
Founded
2015
AUM
≈ $1.0B
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
ChinaHong Kong
Sources
Bocggp
Focus on innovative biotech, medical device, and med‑tech companies with growth and buyout strategies, leveraging industry experience and international insights.
Portfolio
9+
Employees
5+
Founded
2015
AUM
≈ $1.0B
Stages
No stages listed
Industries
No industries listedGeographic scope
ChinaHong Kong
Sources
Showing 3 of 3 matched portfolio companies
RecoveryPlus.health is a remote cardiac rehabilitation platform that utilizes an FDA-listed telehealth system to deliver tailored exercise plans and care management for patients with chronic heart conditions. This service significantly reduces hospital readmission rates to 2% and enhances patient compliance to over 90%, compared to traditional rehab methods.
Funding: $26.1M
Rough estimate of the amount of funding raised
Funding: $26.1M
Rough estimate of the amount of funding raised
Signet Therapeutics develops targeted therapeutics that employ precision medicine techniques to identify and inhibit specific pathways in cancer cells. The company provides personalized treatment options for patients with various cancer types, addressing the limitations of traditional therapies.
Founded 2020
Cure Genetics develops cell and gene therapies utilizing AIMS CAR-NKT and VELPTM AAV platforms to target solid tumors and genetic diseases. The company addresses the need for effective treatments in oncology and complex genetic disorders through its differentiated therapeutic pipeline and global collaborations.
Funding: $9.0M
Rough estimate of the amount of funding raised
Funding: $9.0M
Rough estimate of the amount of funding raised
Showing 6 of 6 unmatched portfolio companies